-+ 0.00%
-+ 0.00%
-+ 0.00%
Marvel Biosciences Grants 59,693 Deferred Share Units to Directors in Lieu of Cash Fees
Share
Listen to the news
Marvel Biosciences Grants 59,693 Deferred Share Units to Directors in Lieu of Cash Fees
  • Marvel Biosciences awarded 59,693 deferred share units to its three independent directors in lieu of cash payment for directors' fees.
  • The deferred share units will all vest on November 18, 2027.
  • Vested deferred share units will be settled upon directors' separation from service and expire 365 days following separation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marvel Biosciences Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611181702NEWSFILECNPR____20261118_324730_1) on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending